SCHEMBL18134

SCHEMBL18134

CCCC1C(=O)NCCN1C[C@H]1CN(S(=O)(=O)c2ccc([N+](=O)[O-])s2)CCN1

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18132 0.85 ALDH1A1 (0.31) ALDH1A1MAPT
SCHEMBL18123 0.81 PKM (0.39) ALDH1A1KDM4ELMNAPOLBMAPT
SCHEMBL17115 0.78 NR1D1 (0.31)
SCHEMBL16510 0.77 GCKR (0.38) ALDH1A1LMNAPOLBMAPT
SCHEMBL17382 0.76 GCKR (0.38)
SCHEMBL17466 0.74 NR1D1 (0.37) ALDH1A1LMNAMAPT
SCHEMBL17165 0.73 NR1D1 (0.31)
SCHEMBL18384 0.73 NR1D1 (0.31)
SCHEMBL12089538 0.73 NR1D1 (0.31)
SCHEMBL17464 0.72 NR1D1 (0.38) ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed